As of 2025-06-19, the Intrinsic Value of LeMaitre Vascular Inc (LMAT) is 82.71 USD. This LMAT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 81.69 USD, the upside of LeMaitre Vascular Inc is 1.20%.
The range of the Intrinsic Value is 41.72 - 935.86 USD
Based on its market price of 81.69 USD and our intrinsic valuation, LeMaitre Vascular Inc (LMAT) is undervalued by 1.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 41.72 - 935.86 | 82.71 | 1.2% |
| DCF (Growth 10y) | 56.07 - 1,168.85 | 107.41 | 31.5% |
| DCF (EBITDA 5y) | 58.93 - 74.57 | 65.51 | -19.8% |
| DCF (EBITDA 10y) | 74.76 - 106.45 | 88.20 | 8.0% |
| Fair Value | 45.71 - 45.71 | 45.71 | -44.04% |
| P/E | 69.81 - 86.73 | 78.29 | -4.2% |
| EV/EBITDA | 41.59 - 65.95 | 53.86 | -34.1% |
| EPV | 14.50 - 27.12 | 20.81 | -74.5% |
| DDM - Stable | 23.82 - 463.22 | 243.52 | 198.1% |
| DDM - Multi | 44.19 - 660.27 | 82.42 | 0.9% |
| Market Cap (mil) | 1,845.38 |
| Beta | 0.72 |
| Outstanding shares (mil) | 22.59 |
| Enterprise Value (mil) | 1,988.02 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.13% |
| Cost of Debt | 5.00% |
| WACC | 6.86% |